4
Changes in Ownership
Keros Therapeutics, Inc. Filed Acc 0001209191-21-032361
Chief Medical Officer sold 1,000 shares at $50.15 ($50,150)
- Chief Medical Officer acquired 1,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4.xml…